Cargando…

Positive screening and carrier results for the England-wide universal newborn sickle cell screening programme by ethnicity and area for 2005–07

AIMS: The overall aim of the new national newborn programme is to identify infants at risk of sickle cell disease to allow early detection and to minimise deaths and complications. METHODS: Universal screening for sickle cell disease was introduced in England between September 2003 and July 2006. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Streetly, Allison, Latinovic, Radoslav, Henthorn, Joan
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Group 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990147/ https://www.ncbi.nlm.nih.gov/pubmed/20591912 http://dx.doi.org/10.1136/jcp.2010.077560

Ejemplares similares

Evaluation of newborn sickle cell screening programme in England: 2010–2016
por: Streetly, Allison, et al.
Publicado: (2018)

Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005–7
por: Streetly, A, et al.
Publicado: (2009)

Trends in hospital admissions for sickle cell disease in England
por: Latinovic, Radoslav, et al.
Publicado: (2013)

Newborn Screening for Sickle Cell Disease in Europe
por: Daniel, Yvonne, et al.
Publicado: (2019)

Newborn Sickle Cell and Thalassaemia Screening Programme: Automating and Enhancing the System to Evaluate the Screening Programme
por: Coppinger, Catherine, et al.
Publicado: (2019)

Newborn screening in Nigeria: will incorporating congenital hypothyroidism with sickle cell disease improve neonatal screening programme?
por: Iroro, Enameguolo Yarhere, et al.
Publicado: (2019)

Performance and characteristics of the Newborn Hearing Screening Programme in England: The first seven years
por: Wood, Sally A, et al.
Publicado: (2015)

Imparting carrier status results detected by universal newborn screening for sickle cell and cystic fibrosis in England: a qualitative study of current practice and policy challenges
por: Parker, Hilda, et al.
Publicado: (2007)

Parents' responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screening
por: Ulph, Fiona, et al.
Publicado: (2015)

Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study
por: Nnodu, Obiageli E, et al.
Publicado: (2020)

Newborn Screening for Sickle Cell Disease: Indian Experience
por: Colah, Roshan B., et al.
Publicado: (2018)

Ethnic disparities in knowledge of cancer screening programmes in the UK
por: Robb, Kathryn, et al.
Publicado: (2010)

The Newborn Hearing Screening Programme in Germany
por: Matulat, Peter, et al.
Publicado: (2018)

Newborn Screening for Sickle Cell Disease in St. Vincent and the Grenadines: Results of a Pilot Newborn Screening Program
por: Williams, Shelly-Ann, et al.
Publicado: (2017)

Screening for sickle cell disease in newborns: a systematic review
por: Runkel, Britta, et al.
Publicado: (2020)

S127: CONSORTIUM ON NEWBORN SCREENING IN AFRICA FOR SICKLE CELL DISEASE
por: Nnodu, O, et al.
Publicado: (2022)

An Evaluation of Three Ways of Communicating Carrier Status Results to the Parents of Children in a Neonatal Sickle Cell Screening Programme
por: Rémus, Christelle, et al.
Publicado: (2020)

Evaluation of newborn screening in the state of Mato Grosso from 2005 to 2019
por: Costa, Roseli Divino, et al.
Publicado: (2023)

A Paper-Based Test for Screening Newborns for Sickle Cell Disease
por: Piety, Nathaniel Z., et al.
Publicado: (2017)

5613004 NEWBORN SCREENING FOR SICKLE CELL DISEASE IN GERMANY - THE FIRST YEAR
por: Lobitz, S., et al.
Publicado: (2023)

A Newborn Screening Program for Sickle Cell Disease in Murcia (Spain)
por: Sánchez-Villalobos, María, et al.
Publicado: (2023)

The impact of COVID-19 on national screening programmes in England
por: Armitage, R.C., et al.
Publicado: (2021)

Flow Cytometry Confirmation Post Newborn Screening for SCID in England
por: Gilmour, Kimberly C.
Publicado: (2021)

Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in England
por: Weidlich, Diana, et al.
Publicado: (2023)

Increasing Incidence, but Lack of Seasonality, of Elevated TSH Levels, on Newborn Screening, in the North of England
por: Pearce, Mark S., et al.
Publicado: (2010)

Global impact of COVID-19 on newborn screening programmes
por: Koracin, Vanesa, et al.
Publicado: (2022)

Whole-genome sequencing in newborn screening? A statement on the continued importance of targeted approaches in newborn screening programmes
por: Howard, Heidi Carmen, et al.
Publicado: (2015)

Inequalities in colorectal cancer screening participation in the first round of the national screening programme in England
por: von Wagner, C, et al.
Publicado: (2009)

Editorial for Special Issue “Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies”
por: Colombatti, Raffaella, et al.
Publicado: (2019)

Newborn Sickle Cell Disease Screening Using Electrospray Tandem Mass Spectrometry
por: Daniel, Yvonne, et al.
Publicado: (2018)

The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular Testing
por: Zhou, Janet R., et al.
Publicado: (2021)

The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology
por: Green, Nancy S., et al.
Publicado: (2022)

Operational analysis of the national sickle cell screening programme in the Republic of Uganda
por: Hernandez, Arielle G., et al.
Publicado: (2021)

Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries
por: Archer, Natasha M, et al.
Publicado: (2022)

Improving regional universal newborn hearing screening programmes in Italy
por: MOLINI, E., et al.
Publicado: (2016)

Evaluating genetic ancestry and self-reported ethnicity in the context of carrier screening
por: Shraga, Roman, et al.
Publicado: (2017)

Clinical Utility of Confirmatory Genetic Testing to Differentiate Sickle Cell Trait from Sickle-β(+)-Thalassemia by Newborn Screening
por: Shook, Lisa M., et al.
Publicado: (2020)

COVID-19 Infection and Outcomes in Newborn Screening Cohorts of Sickle Cell Trait and Sickle Cell Disease in Michigan and Georgia
por: Paulukonis, Susan T., et al.
Publicado: (2023)

Newborn Screening for Sickle Cell Disease in the Caribbean: An Update of the Present Situation and of the Disease Prevalence
por: Knight-Madden, Jennifer, et al.
Publicado: (2019)

A Multi-centre Survey of Acceptability of Newborn Screening for Sickle Cell Disease in Nigeria
por: Nnodu, Obiageli E, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6418a9jfgun4q3age2f52io3kb